ENVVENO MEDICAL CORPORATION's ticker is and the CUSIP is 29415J106. A total of 26 filers reported holding ENVVENO MEDICAL CORPORATION in Q4 2021. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $75,460 | +75.0% | 14,000 | 0.0% | 0.02% | +72.7% |
Q2 2023 | $43,120 | -61.6% | 14,000 | -41.7% | 0.01% | -63.3% |
Q1 2023 | $112,320 | -8.2% | 24,000 | 0.0% | 0.03% | -9.1% |
Q4 2022 | $122,400 | -18.9% | 24,000 | 0.0% | 0.03% | -21.4% |
Q3 2022 | $151,000 | +65.9% | 24,000 | 0.0% | 0.04% | +82.6% |
Q2 2022 | $91,000 | -5.2% | 24,000 | +60.0% | 0.02% | +15.0% |
Q1 2022 | $96,000 | +4.3% | 15,000 | +7.1% | 0.02% | +17.6% |
Q4 2021 | $92,000 | – | 14,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 401,200 | $2,556,000 | 2.70% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 219,180 | $1,396,000 | 0.14% |
Perceptive Advisors | 781,615 | $4,978,000 | 0.10% |
Kepos Capital LP | 50,000 | $319,000 | 0.02% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 15,000 | $96,000 | 0.02% |
TWO SIGMA INVESTMENTS, LP | 33,372 | $213,000 | 0.00% |
TWO SIGMA ADVISERS, LP | 49,600 | $316,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 2,045 | $13,000 | 0.00% |
NORTHERN TRUST CORP | 13,906 | $89,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |